COA
No files available
NMR
No files available
Primary record
Daraxonrasib
- CAS
- 2765081-21-6
- Stock
- 2800g
- Purity
- 99.1%
- PubChem CID
- 164726578
- SMILES
- CCN1C2=C3C=C(C=C2)C4=CSC(=N4)C[C@@H](C(=O)N5CCC[C@H](N5)C(=O)OCC(CC3=C1C6=C(N=CC(=C6)N7CCN(CC7)C)[C@H](C)OC)(C)C)NC(=O)[C@H]8C[C@@H]8C
- Molecular Formula
- C44H58N8O5S
- Molecular Weight
- 811.066
- Exact Mass
- 810.4251
- InChI
- InChI=1S/C44H58N8O5S/c1-8-51-37-12-11-28-19-31(37)33(40(51)32-20-29(23-45-39(32)27(3)56-7)50-16-14-49(6)15-17-50)22-44(4,5)25-57-43(55)34-10-9-13-52(48-34)42(54)35(21-38-46-36(28)24-58-38)47-41(53)30-18-26(30)2/h11-12,19-20,23-24,26-27,30,34-35,48H,8-10,13-18,21-22,25H2,1-7H3,(H,47,53)/t26-,27-,30-,34-,35-/m0/s1
- InChIKey
- FVICRBSEYSHKFY-JYQNNKODSA-N
- LogP
- 5.6103
- TPSA
- 134.16
Names and synonyms
- Daraxonrasib
- RAS-IN-2
- RMC-6236
- daraxonrasib [INN]
- RAS Inhibitor A122
- A1AHB
- B6T47Y2UAP
- RefChem:1082975
- DARAXONRASIB [USAN]
- RMC6236
- SCHEMBL25774297
- SCHEMBL31152365
- EX-A6631B
- GTPL13368
- 2765081-21-6
- RMC 6236 [WHO-DD]
- GLXC-27997
- RMC 6236
- NSC852671
- AT43357
- NSC-852671
- RMC-0706236
- SY347092
- HY-148439
- CS-0626513
- A948815
- pyridazinacycloundecaphane-4-yl)-2-methylcyclopropane-1-carboxamide
- (1S,2S)-N-((63S,4S,Z)-11-Ethyl-12-(2-((S)-1-methoxyethyl)-5-(4-methylpiperazin-1-yl)pyridin-3-yl )-10,10-dimethyl-5,7-dioxo-61,62,63,64,65,66-hexahydro-11H-8-oxa-2(4,2)-thiazola-1(5,3)-indola -6(1,3)-
- (1S,2S)-N-[(12M,4S,63S)-11-ethyl-12-{2-[(1S)-1-methoxyethyl]-5-(4-methylpiperazin-1-yl)pyridin-3-yl}-10,10-dimethyl-5,7-dioxo-11H-8-oxa-1(5,3)-indola-6(1,3)-[1,2]diazinana-2(4,2)-[1,3]thiazolacycloundecaphan-4-yl]-2-methylcyclopropane-1-carboxamide
- (1S,2S)-N-[(2R,14S,18S)-1-Ethyl-18,19,20,21-tetrahydro-2-[2-[(1S)-1-methoxyethyl]-5-(4-methyl-1-piperazinyl)-3-pyridinyl]-25,25-dimethyl-15,22-dioxo-17H-5,3-([4,2]-endo-thiazolopropano[1,3]-endo-pyridazinomethanoxypropano)-1H-indol-14-yl]-2-methyl-cyclopropanecarboxamide